JPRN-UMIN000001025已完成1 期
Phase I study of preoperative Docetaxel, Cisplatin and S-1 for patients with advanced gastric cancer - Phase I study of preoperative DCS therapy for advanced gastric cancer
Dept. of Gastroenterologic Surgery, Kanazawa University Hospital0 个研究点目标入组 24 人开始时间: 2008年2月15日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Active infection 2. Other severe complications 3. Active double cancer 4. CNS metastasis 5. Pericardiac fluid 6. Mortor paralysis or peripheral neural disturbance. 7. History of severe allergy against drug. 8. Severe peritoneal metastasis 9. Pregnant women or women who like to be pregnant. 10. Doctor' s dicision not to be registered to this study.
研究者
相似试验
已完成
不适用
Phase II study of preoperative Docetaxel, cisplatin and S-1 in patients with clinically respectable type 4 , large type 3 and with extensive lymph node metastasis gastric cancerGastric cancerJPRN-UMIN000003052Department of Surgery, Yokohama City University30
已完成
1 期
Phase I study of Docetaxel, Cisplatin and S-1 in patients with advanced or recurrent gastric cancerGastric cancerJPRN-UMIN000000978Shizuoka Cancer Center18
未知
2 期
A phase II study of combination Docetaxel, Cisplatin, and S-1 as neoadjuvant chemotherapy for advanced gastric cancer.advanced gastric cancerJPRN-UMIN000000801Dept. of Internal Medicine(4)30
Unknown
2 期
The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus AdenocarcinomaGastric CancerNCT00674167National University Hospital, Singapore21
已完成
1 期
Phase 1 study of Docetaxel and Oxaliplatin and TS-1 for unresectable / recurrent gastric cancer (KOGC-06)unresectable / recurrent gastric cancerJPRN-UMIN000015723Keio University School of Medicine, Department of Surgery5